Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Schoemaker

Showing results (41-50 of 91) with videos related to

Pageof 10
Sort By:
Clinical Pharmacology and Therapeutics|November 1, 1996
Effects of increased liver blood flow on the kinetics and dynamics of recombinant tissue-type plasminogen activatorJ M van Griensven, L G Huisman, T Stuurman, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1995
Amoxicillin pharmacokinetics in preterm infants with gestational ages of less than 32 weeksJ J Huisman-de Boer, J N van den Anker, M Vogel, et al.
American Journal of Ophthalmology|June 13, 1998
Dexamethasone concentration in vitreous and serum after oral administrationO Weijtens, R C Schoemaker, A F Cohen, et al.
Clinical Pharmacology and Therapeutics|September 1, 1990
The influence of infusion rate on the hemodynamic effects of felodipineA F Cohen, M A van Hall, J van Harten, et al.
European Journal of Clinical Pharmacology|May 25, 2001
The effect of warfarin on the pharmacokinetics and pharmacodynamics of napsagatran in healthy male volunteersR A Faaij, J M van Griensven, R C Schoemaker, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1995
Once-daily versus twice-daily administration of ceftazidime in the preterm infantJ N van den Anker, R C Schoemaker, B J van der Heijden, et al.
British Journal of Clinical Pharmacology|November 1, 1995
Ceftazidime pharmacokinetics in preterm infants: effect of postnatal age and postnatal exposure to indomethacinJ N van den Anker, W C Hop, R C Schoemaker, et al.
Clinical Pharmacology and Therapeutics|February 18, 1998
Effects of liver blood flow on the pharmacokinetics of tissue-type plasminogen activator (alteplase) during thrombolysis in patients with acute myocardial infarctionJ M van Griensven, R W Koster, J Burggraaf, et al.
Clinical Pharmacology and Therapeutics|September 8, 2000
A pharmacodynamic Markov mixed-effects model for the effect of temazepam on sleepM O Karlsson, R C Schoemaker, B Kemp, et al.
American Journal of Physiology. Endocrinology and Metabolism|June 19, 2001
Sympathovagal imbalance in hyperthyroidismJ Burggraaf, J H Tulen, S Lalezari, et al.
Pageof 10

Showing results (41-50 of 91) with videos related to

Sort By:
Pageof 10
Clinical Pharmacology and Therapeutics|November 1, 1996
Effects of increased liver blood flow on the kinetics and dynamics of recombinant tissue-type plasminogen activatorJ M van Griensven, L G Huisman, T Stuurman, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1995
Amoxicillin pharmacokinetics in preterm infants with gestational ages of less than 32 weeksJ J Huisman-de Boer, J N van den Anker, M Vogel, et al.
American Journal of Ophthalmology|June 13, 1998
Dexamethasone concentration in vitreous and serum after oral administrationO Weijtens, R C Schoemaker, A F Cohen, et al.
Clinical Pharmacology and Therapeutics|September 1, 1990
The influence of infusion rate on the hemodynamic effects of felodipineA F Cohen, M A van Hall, J van Harten, et al.
European Journal of Clinical Pharmacology|May 25, 2001
The effect of warfarin on the pharmacokinetics and pharmacodynamics of napsagatran in healthy male volunteersR A Faaij, J M van Griensven, R C Schoemaker, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1995
Once-daily versus twice-daily administration of ceftazidime in the preterm infantJ N van den Anker, R C Schoemaker, B J van der Heijden, et al.
British Journal of Clinical Pharmacology|November 1, 1995
Ceftazidime pharmacokinetics in preterm infants: effect of postnatal age and postnatal exposure to indomethacinJ N van den Anker, W C Hop, R C Schoemaker, et al.
Clinical Pharmacology and Therapeutics|February 18, 1998
Effects of liver blood flow on the pharmacokinetics of tissue-type plasminogen activator (alteplase) during thrombolysis in patients with acute myocardial infarctionJ M van Griensven, R W Koster, J Burggraaf, et al.
Clinical Pharmacology and Therapeutics|September 8, 2000
A pharmacodynamic Markov mixed-effects model for the effect of temazepam on sleepM O Karlsson, R C Schoemaker, B Kemp, et al.
American Journal of Physiology. Endocrinology and Metabolism|June 19, 2001
Sympathovagal imbalance in hyperthyroidismJ Burggraaf, J H Tulen, S Lalezari, et al.
Pageof 10